| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.0007 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0009 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.002 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.19 | 0.003 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |